INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 369 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $359,772 | -22.5% | 11,378 | 0.0% | 0.60% | +17.8% |
| Q2 2023 | $463,995 | +16.3% | 11,378 | +6.3% | 0.51% | +4.3% |
| Q1 2023 | $398,975 | +6.8% | 10,705 | 0.0% | 0.49% | +34.0% |
| Q4 2022 | $373,497 | -36.3% | 10,705 | -10.4% | 0.36% | -37.5% |
| Q3 2022 | $586,000 | -1.5% | 11,954 | +4.0% | 0.58% | +6.2% |
| Q2 2022 | $595,000 | -0.2% | 11,490 | +40.1% | 0.55% | +27.0% |
| Q1 2022 | $596,000 | +3.7% | 8,200 | +68.7% | 0.43% | +9.1% |
| Q4 2021 | $575,000 | -42.8% | 4,862 | -35.2% | 0.40% | -0.5% |
| Q3 2021 | $1,006,000 | +180.2% | 7,500 | +67.9% | 0.40% | +216.7% |
| Q1 2021 | $359,000 | -97.0% | 4,468 | -98.0% | 0.13% | -95.7% |
| Q4 2020 | $11,968,000 | +447.2% | 220,000 | +100.0% | 2.94% | +353.5% |
| Q3 2020 | $2,187,000 | – | 110,000 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |